Clinical Trial Update: Real-World Safety and Effectiveness of Sotyktu (Deucravacitinib) in Patients With Moderate-to-Severe Plaque Psoriasis in Korea

View source ↗

Summary

An observational study evaluating the real-world safety and effectiveness of deucravacitinib (Sotyktu) in Korean adults with moderate-to-severe plaque psoriasis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Sotyktu (Deucravacitinib)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Moderate-to-severe Plaque Psoriasis | Status: RECRUITING